Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Interfascial Block for Trapezius Myofascial Syndrome in Fibromyalgia
2024-520345-23-00Phase 4Authorised
- Sponsor
- IDIBAPS
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone, lidocaine and bupivacaine in chronic myofascial pain (CMP) and fibromyalgia (FM), sponsored by IDIBAPS. Primary endpoint: Regional trapezius pain intensity. Planned start Jan 2025; status: authorised.
02
Drugs
triamcinolonelidocainebupivacaine
03
Conditions
chronic myofascial pain (CMP)fibromyalgia (FM)
Beyond the preview
Go deeper on 2024-520345-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520345-23-00.